A Study in Healthy Men to Test How BI 685509 is Processed in the Body
NCT05515328
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
[¹⁴C] BI 685509 formulation 1
DRUG:
[¹⁴C] BI 685509 formulation 2
DRUG:
BI 685509 formulation 3
Sponsor
Boehringer Ingelheim